Rachel Katz, MD, BS
Biography
Rachel Katz, MD, is a psychiatrist who specializes in interventional psychiatry and mood disorders.
Dr. Katz focuses on diagnosing and treating various mental health conditions, including depression and anxiety, using advanced techniques to improve patient outcomes. She employs a range of approaches to manage these conditions, such as transcranial magnetic stimulation (TMS) and other therapeutic interventions.
An assistant professor of psychiatry at Yale School of Medicine, Dr. Katz received her medical training from Case Western Reserve University School of Medicine.
Titles
- Assistant Professor of Psychiatry
- Co-Director - Transcranial Magnetic Stimulation (TMS) Service, Psychiatry
Education & Training
- Fellow - Interventional PsychiatryYale New Haven Hospital (2018)
- Chief Resident - Interventional Psychiatry ServiceYale New Haven Hospital (2017)
- ResidentYale New Haven Hospital (2017)
- MDCase Western Reserve University School of Medicine (2013)
- BSNorthwestern University, Religion, Communication Sciences, Dance (2008)
Additional Information
- Distinguished Women in Medicine - 100 Years of Women at Yale School of Medicine : (2020)
- Ira Levine Award : Yale Department of Psychiatry (2015)
- Alpha Omega Alpha (AOA) Honor Medical Society : (2013)
- Leah M. Dickstein Women in Psychiatry Award : Case Western Reserve University School of Medicine (2012)
- Dean's Summer Grant Awardee : Case Western Reserve University (2010)
- Golden Key Award: International Honour Society (2008)
- Viewbook Featured Student : Northwestern University, School of Communication (2008)
- Award for Departmental Excellence : Northwestern University, School of Communication (2007), (2008)
- Century Scholar Award: Northwestern University (2006), (2007), (2008)
- Dean's List : Northwestern University (2005), (2006), (2007), (2008)
- Yale Medicine (2025 - Present): Featured interviewee for Yale Medicine article "What is Interventional Psychiatry?"
- Yale Medicine (2025 - Present): Featured interviewee for article “Yale-Led Study Will Compare Effectiveness of IV Ketamine and Esketamine Nasal Spray”
- Yale Medicine (2025 - Present): Featured interviewee for Yale Medicine article “New Device at Yale Interventional Psychiatry Service Shortens TMS Delivery Time for Most Patients”
- West Haven VA (2024 - Present): Data Monitoring Safety Board: Safety, Tolerability, Electrophysiological Effects of Dimethyltryptamine (DMT) in Humans led by Cyril D’Souza MD
- International Society for Electroconvulsive Therapy and Neuromodulation Education Committee (2024 - Present): Committee Member
- Nature (2024 - Present): Reviewer
- Neuropsychiatric Disease and Treatment (2023 - Present): Reviewer
- Yale New Haven Hospital (2022 - Present): Care Pathway Clinical Consensus Group for Primary Care Management of Depression
- Yale New Haven Hospital (2021 - 2022): Care Pathway Clinical Consensus Group for Treatment Resistant Depression (TRD)
- Yale New Haven Hospital (2021 - Present): Care Pathway Clinical Consensus Group for Acute Mania
- Elliott SI, B Katz R, B Ostroff R, Ansari M, Holmes SE, Sanacora G. Ketamine Versus Electroconvulsive Therapy for the Treatment of Depression: A Guide for Clinicians. Focus (Am Psychiatr Publ) 2025, 23: 195-205. PMID: 40235610, DOI: 10.1176/appi.focus.20240040.
- Hughes M, Cohen T, Ostroff R, Katz R. Safe Delivery of Electroconvulsive Therapy in a Patient With Obstructive Sleep Apnea and a Hypoglossal Nerve Stimulator: A Case Report. J ECT 2024 PMID: 39589131, DOI: 10.1097/YCT.0000000000001089.
- Prescribing non-pharmacologic interventions: the age of interventional psychiatryCahill J, Gallagher K, editors. Psychiatric Prescribing: The How, The Why and the Why Not. Cambridge: Cambridge University Press.
- TMS Neuromodulation chapterYale Department of Psychiatry Manual of Interventional Psychiatry, accepted by Oxford Press
- Kitay BM, Katz RB, Wilkinson ST, Ostroff RB. The Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary Lesion. Journal Of Ect 2019, 35: e4-e5. PMID: 29952859, PMCID: PMC6309946, DOI: 10.1097/yct.0000000000000516.
- Kitay B, Katz R, Wilkinson S, Ostroff R. The Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary Lesion. Journal Of Ect 2018, 1. DOI: 10.1097/00124509-900000000-99225.
- The Use of Electroconvulsive Therapy in Late-Life Psychiatric DisordersOstroff RB, Katz RB. The Use of Electroconvulsive Therapy in Late-Life Psychiatric Disorders. Current Treatment Options in Psychiatry. June 2018, Volume 5, Issue 2, 228-241.
- A Patient’s Request to Withdraw a Ventricular Assist Device: The Role of the Consulting Psychiatrist Among Evolving Medical TechnologiesKatz RB. A Patient’s Request to Withdraw a Ventricular Assist Device: The Role of the Consulting Psychiatrist Among Evolving Medical Technologies. American Journal of Psychiatry Residents’ Journal. 2018.
- Wilkinson S, Ostroff R, Katz R, Krystal J. Erratum to: Ketamine: A Promising Rapid-Acting Antidepressant. 2018, e1-e1. DOI: 10.1007/978-981-10-6577-4_24.
- Wilkinson S, Webler R, Katz R, Toprak M, Ostroff R, Sanacora G. S106. Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital. Biological Psychiatry 2018, 83: s388. DOI: 10.1016/j.biopsych.2018.02.997.
- Suicide Risk in Bipolar Disorder: Comparing Lithium, Divalproex, and CarbamazepineSuicide Risk in Bipolar Disorder: Comparing Lithium, Divalproex, and Carbamazepine. Fifty Studies Every Psychiatrist Should Know. Oxford Press 2018.
- tDCS ChapterYale Department of Psychiatry Manual of Interventional Psychiatry, accepted by Oxford Press
- Ostroff R, Katz R. The Use of Electroconvulsive Therapy in Late-Life Psychiatric Disorders. Current Treatment Options In Psychiatry 2018, 5: 228-241. DOI: 10.1007/s40501-018-0144-2.
- Life Expectancy: A Primer with Focus on Neurological and Psychiatric ConditionsKatz RT, Katz RB. Life Expectancy: A Primer with Focus on Neurological and Psychiatric Conditions. AMA Guides Newsletter; American Medical Association. Nov/Dec 2017.
- Katz R, Cherry B. Integrating Behavioral Health and Primary Care. American Journal Of Psychiatry 2017, 174: 1125-1125. DOI: 10.1176/appi.ajp.2017.17080927.
- Wilkinson S, Ostroff R, Katz R, Krystal J. Ketamine: A Promising Rapid-Acting Antidepressant. 2017, 223-239. DOI: 10.1007/978-981-10-6577-4_16.
- Looking ForwardKatz RB. Looking Forward. American Journal of Psychiatry Residents' Journal. 2017 Aug. 12(8): 2.
- Letter to the Editor: A Successful Course of ECT in a Patient with Epilepsy and a Posterior Fossa Titanium Plate. Journal of ECT. Accepted for publication 11/15/2016.
- Katz RB, Helgeson L, Ostroff R. A Case of Anesthesia Mumps with Electroconvulsive Therapy. Journal Of Ect 2017, 33: e6. PMID: 27922460, DOI: 10.1097/yct.0000000000000370.
- Katz R, Bukanova E, Ostroff R. Procedural Consolidation During Electroconvulsive Therapy for a Patient With Severe Tourette Syndrome. The Journal Of ECT 2017, 33: e7-e8. PMID: 28009622, DOI: 10.1097/YCT.0000000000000378.
- Packer CD, Katz RB, Iacopetti CL, Krimmel JD, Singh MK. A Case Suspended in Time. Academic Medicine 2017, 92: 152-156. PMID: 27097050, DOI: 10.1097/acm.0000000000001199.
- van Schalkwyk GI, Katz RB, Resignato J, van Schalkwyk SC, Rohrbaugh RM. Effective Research Mentorship for Residents: Meeting the Needs of Early Career Physicians. Academic Psychiatry 2016, 41: 326-332. PMID: 27766554, DOI: 10.1007/s40596-016-0625-9.
- Katz RB. Residents Can Help Curb the Opiate Epidemic. Psychiatric News. August 1, 2016.
- A Call to Arms: The Role of the Psychiatry Resident in the Current Opioid EpidemicA Call to Arms: The Role of the Psychiatry Resident in the Current Opioid Epidemic http://ajp.psychiatryonline.org/pb/assets/raw/journals/residents-journal/2016/June_2016.pdf#page=2
- Evolving Approaches to the Pharmacologic Treatment of Alcohol WithdrawalEvolving Approaches to the Pharmacologic Treatment of Alcohol Withdrawal. American Journal of Psychiatry Residents' Journal. 2014 Sep;9(9). http://ajp.psychiatryonline.org/pb/assets/raw/journals/residents-journal/2014/Sept_2014.pdf
- Katz RB, Packer CD. Lithium Toxicity Presenting as Transient Transcortical Motor Aphasia: A Case Report. Journal Of The Academy Of Consultation-Liaison Psychiatry 2013, 55: 87-91. PMID: 24011866, DOI: 10.1016/j.psym.2013.05.004.
Biography
Rachel Katz, MD, is a psychiatrist who specializes in interventional psychiatry and mood disorders.
Dr. Katz focuses on diagnosing and treating various mental health conditions, including depression and anxiety, using advanced techniques to improve patient outcomes. She employs a range of approaches to manage these conditions, such as transcranial magnetic stimulation (TMS) and other therapeutic interventions.
An assistant professor of psychiatry at Yale School of Medicine, Dr. Katz received her medical training from Case Western Reserve University School of Medicine.
Titles
- Assistant Professor of Psychiatry
- Co-Director - Transcranial Magnetic Stimulation (TMS) Service, Psychiatry
Education & Training
- Fellow - Interventional PsychiatryYale New Haven Hospital (2018)
- Chief Resident - Interventional Psychiatry ServiceYale New Haven Hospital (2017)
- ResidentYale New Haven Hospital (2017)
- MDCase Western Reserve University School of Medicine (2013)
- BSNorthwestern University, Religion, Communication Sciences, Dance (2008)
Additional Information
- Distinguished Women in Medicine - 100 Years of Women at Yale School of Medicine : (2020)
- Ira Levine Award : Yale Department of Psychiatry (2015)
- Alpha Omega Alpha (AOA) Honor Medical Society : (2013)
- Leah M. Dickstein Women in Psychiatry Award : Case Western Reserve University School of Medicine (2012)
- Dean's Summer Grant Awardee : Case Western Reserve University (2010)
- Golden Key Award: International Honour Society (2008)
- Viewbook Featured Student : Northwestern University, School of Communication (2008)
- Award for Departmental Excellence : Northwestern University, School of Communication (2007), (2008)
- Century Scholar Award: Northwestern University (2006), (2007), (2008)
- Dean's List : Northwestern University (2005), (2006), (2007), (2008)
- Yale Medicine (2025 - Present): Featured interviewee for Yale Medicine article "What is Interventional Psychiatry?"
- Yale Medicine (2025 - Present): Featured interviewee for article “Yale-Led Study Will Compare Effectiveness of IV Ketamine and Esketamine Nasal Spray”
- Yale Medicine (2025 - Present): Featured interviewee for Yale Medicine article “New Device at Yale Interventional Psychiatry Service Shortens TMS Delivery Time for Most Patients”
- West Haven VA (2024 - Present): Data Monitoring Safety Board: Safety, Tolerability, Electrophysiological Effects of Dimethyltryptamine (DMT) in Humans led by Cyril D’Souza MD
- International Society for Electroconvulsive Therapy and Neuromodulation Education Committee (2024 - Present): Committee Member
- Nature (2024 - Present): Reviewer
- Neuropsychiatric Disease and Treatment (2023 - Present): Reviewer
- Yale New Haven Hospital (2022 - Present): Care Pathway Clinical Consensus Group for Primary Care Management of Depression
- Yale New Haven Hospital (2021 - 2022): Care Pathway Clinical Consensus Group for Treatment Resistant Depression (TRD)
- Yale New Haven Hospital (2021 - Present): Care Pathway Clinical Consensus Group for Acute Mania
- Elliott SI, B Katz R, B Ostroff R, Ansari M, Holmes SE, Sanacora G. Ketamine Versus Electroconvulsive Therapy for the Treatment of Depression: A Guide for Clinicians. Focus (Am Psychiatr Publ) 2025, 23: 195-205. PMID: 40235610, DOI: 10.1176/appi.focus.20240040.
- Hughes M, Cohen T, Ostroff R, Katz R. Safe Delivery of Electroconvulsive Therapy in a Patient With Obstructive Sleep Apnea and a Hypoglossal Nerve Stimulator: A Case Report. J ECT 2024 PMID: 39589131, DOI: 10.1097/YCT.0000000000001089.
- Prescribing non-pharmacologic interventions: the age of interventional psychiatryCahill J, Gallagher K, editors. Psychiatric Prescribing: The How, The Why and the Why Not. Cambridge: Cambridge University Press.
- TMS Neuromodulation chapterYale Department of Psychiatry Manual of Interventional Psychiatry, accepted by Oxford Press
- Kitay BM, Katz RB, Wilkinson ST, Ostroff RB. The Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary Lesion. Journal Of Ect 2019, 35: e4-e5. PMID: 29952859, PMCID: PMC6309946, DOI: 10.1097/yct.0000000000000516.
- Kitay B, Katz R, Wilkinson S, Ostroff R. The Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary Lesion. Journal Of Ect 2018, 1. DOI: 10.1097/00124509-900000000-99225.
- The Use of Electroconvulsive Therapy in Late-Life Psychiatric DisordersOstroff RB, Katz RB. The Use of Electroconvulsive Therapy in Late-Life Psychiatric Disorders. Current Treatment Options in Psychiatry. June 2018, Volume 5, Issue 2, 228-241.
- A Patient’s Request to Withdraw a Ventricular Assist Device: The Role of the Consulting Psychiatrist Among Evolving Medical TechnologiesKatz RB. A Patient’s Request to Withdraw a Ventricular Assist Device: The Role of the Consulting Psychiatrist Among Evolving Medical Technologies. American Journal of Psychiatry Residents’ Journal. 2018.
- Wilkinson S, Ostroff R, Katz R, Krystal J. Erratum to: Ketamine: A Promising Rapid-Acting Antidepressant. 2018, e1-e1. DOI: 10.1007/978-981-10-6577-4_24.
- Wilkinson S, Webler R, Katz R, Toprak M, Ostroff R, Sanacora G. S106. Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital. Biological Psychiatry 2018, 83: s388. DOI: 10.1016/j.biopsych.2018.02.997.
- Suicide Risk in Bipolar Disorder: Comparing Lithium, Divalproex, and CarbamazepineSuicide Risk in Bipolar Disorder: Comparing Lithium, Divalproex, and Carbamazepine. Fifty Studies Every Psychiatrist Should Know. Oxford Press 2018.
- tDCS ChapterYale Department of Psychiatry Manual of Interventional Psychiatry, accepted by Oxford Press
- Ostroff R, Katz R. The Use of Electroconvulsive Therapy in Late-Life Psychiatric Disorders. Current Treatment Options In Psychiatry 2018, 5: 228-241. DOI: 10.1007/s40501-018-0144-2.
- Life Expectancy: A Primer with Focus on Neurological and Psychiatric ConditionsKatz RT, Katz RB. Life Expectancy: A Primer with Focus on Neurological and Psychiatric Conditions. AMA Guides Newsletter; American Medical Association. Nov/Dec 2017.
- Katz R, Cherry B. Integrating Behavioral Health and Primary Care. American Journal Of Psychiatry 2017, 174: 1125-1125. DOI: 10.1176/appi.ajp.2017.17080927.
- Wilkinson S, Ostroff R, Katz R, Krystal J. Ketamine: A Promising Rapid-Acting Antidepressant. 2017, 223-239. DOI: 10.1007/978-981-10-6577-4_16.
- Looking ForwardKatz RB. Looking Forward. American Journal of Psychiatry Residents' Journal. 2017 Aug. 12(8): 2.
- Letter to the Editor: A Successful Course of ECT in a Patient with Epilepsy and a Posterior Fossa Titanium Plate. Journal of ECT. Accepted for publication 11/15/2016.
- Katz RB, Helgeson L, Ostroff R. A Case of Anesthesia Mumps with Electroconvulsive Therapy. Journal Of Ect 2017, 33: e6. PMID: 27922460, DOI: 10.1097/yct.0000000000000370.
- Katz R, Bukanova E, Ostroff R. Procedural Consolidation During Electroconvulsive Therapy for a Patient With Severe Tourette Syndrome. The Journal Of ECT 2017, 33: e7-e8. PMID: 28009622, DOI: 10.1097/YCT.0000000000000378.
- Packer CD, Katz RB, Iacopetti CL, Krimmel JD, Singh MK. A Case Suspended in Time. Academic Medicine 2017, 92: 152-156. PMID: 27097050, DOI: 10.1097/acm.0000000000001199.
- van Schalkwyk GI, Katz RB, Resignato J, van Schalkwyk SC, Rohrbaugh RM. Effective Research Mentorship for Residents: Meeting the Needs of Early Career Physicians. Academic Psychiatry 2016, 41: 326-332. PMID: 27766554, DOI: 10.1007/s40596-016-0625-9.
- Katz RB. Residents Can Help Curb the Opiate Epidemic. Psychiatric News. August 1, 2016.
- A Call to Arms: The Role of the Psychiatry Resident in the Current Opioid EpidemicA Call to Arms: The Role of the Psychiatry Resident in the Current Opioid Epidemic http://ajp.psychiatryonline.org/pb/assets/raw/journals/residents-journal/2016/June_2016.pdf#page=2
- Evolving Approaches to the Pharmacologic Treatment of Alcohol WithdrawalEvolving Approaches to the Pharmacologic Treatment of Alcohol Withdrawal. American Journal of Psychiatry Residents' Journal. 2014 Sep;9(9). http://ajp.psychiatryonline.org/pb/assets/raw/journals/residents-journal/2014/Sept_2014.pdf
- Katz RB, Packer CD. Lithium Toxicity Presenting as Transient Transcortical Motor Aphasia: A Case Report. Journal Of The Academy Of Consultation-Liaison Psychiatry 2013, 55: 87-91. PMID: 24011866, DOI: 10.1016/j.psym.2013.05.004.